Background and purpose The COVID-19 pandemic resulted in an accelerated
recommendation to use five-fraction radiotherapy schedules, according to the FAST-and …

Background: During the SARS-CoV-2 virus pandemic, University Hospital Birmingham NHS
Trust Oncology Department incorporated the ultrahypofractionated regime of 26Gy/5 …

Purpose: Hypofractionated radiotherapy was recommended for several cancer sites to
reduce outpatient visits during the coronavirus disease 2019 pandemic. This study aimed to …

Methods Ultrahypofractionation was offered to all eligible patients and was therefore not
regarded as a prospective trial. Informed consent was achieved for radiation therapy. Data …

On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a
global pandemic. Public health officials have urged communities to minimize transmission …

Background The indirect impact of the COVID-19 pandemic on cancer outcomes is of
increasing concern. However, the extent to which key treatment modalities have been …

Purpose/Objective (s) In March 2020, a 1-week hypofractionated adjuvant breast
radiotherapy schedule, 26 Gy in 5 fractions, was implemented to reduce the risk of COVID …

Purpose/Objective (s) In response to the COVID-19 pandemic, radiotherapy (RT)
departments around the world created new policies as a means of reducing risk of exposure …

Aims Adjuvant radiotherapy is recommended for most patients with early breast cancer
(EBC) receiving breast-conserving surgery and those at moderate/high risk of recurrence …

PURPOSE The COVID-19 pandemic has profoundly affected cancer care worldwide,
including radiation therapy (RT) for breast cancer (BC), because of risk-based resource …